Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant

Conditions:   Breast Cancer;   Chronic Myeloproliferative Disorders;   Gestational Trophoblastic Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Testicular Germ Cell TumorInterventions:   Drug: Aprepitant;   Drug: Cyclophosphamide;   Drug: Dexamethasone;   Drug: Granisetron hydrochlorideSponsors:   Barbara Ann Karmanos Cancer Institute;   National Cancer Institute (NCI)Completed - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials